| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $110.7M | +6.8% | +19.3% |
| Cost of Revenue | $53.6M | +7.8% | +14.6% |
| R&D Expense | $19.7M | +15.0% | -17.7% |
| SG&A Expense | $76.1M | +9.1% | +19.5% |
| Operating Income | -$45.9M | -39.4% | -10.4% |
| Pre-tax Income | -$44.0M | -45.4% | -12.3% |
| Income Tax | $43K | -83.0% | -75.4% |
| Net Income | -$44.0M | -44.3% | -11.9% |
| EPS (Basic) | -$0.71 | -42.0% | -7.6% |
| EPS (Diluted) | -$0.71 | -42.0% | -7.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $122.7M | -17.4% | -41.7% |
| Short-term Investments | $49.0M | -0.7% | +4.9% |
| Accounts Receivable | $64.2M | +28.1% | +28.4% |
| Inventory | $33.5M | +1.8% | +60.7% |
| Current Assets | $323.4M | +6.4% | -4.4% |
| Total Assets | $676.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.4M | -70.8% | — |
| Capital Expenditures | $17.9M | +79.1% | — |
| Investing Cash Flow | -$22.6M | -127.9% | — |
| Financing Cash Flow | $4.4M | +1388.6% | — |
| Free Cash Flow | -$60.2M | -73.1% | — |
| +13.5% |
| Current Liabilities | $120.0M | +49.1% | +60.0% |
| Total Liabilities | $221.1M | +21.5% | +42.2% |
| Stockholders' Equity | $455.1M | -0.2% | +3.4% |